Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

572 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC risk groups in metastatic renal cell carcinoma: a meta-analysis.
Rizzo A, Mollica V, Santoni M, Rosellini M, Marchetti A, Ricci AD, Grilli G, Greco A, Montironi R, Ardizzoni A, Massari F. Rizzo A, et al. Among authors: marchetti a. Immunotherapy. 2021 Apr 28. doi: 10.2217/imt-2021-0005. Online ahead of print. Immunotherapy. 2021. PMID: 33906376
Exploring the association between metastatic sites and androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer patients: A meta-analysis of prospective clinical trials.
Rizzo A, Mollica V, Rosellini M, Marchetti A, Ricci AD, Fiorentino M, Battelli N, Santoni M, Massari F. Rizzo A, et al. Among authors: marchetti a. Pathol Res Pract. 2021 Apr 9;222:153440. doi: 10.1016/j.prp.2021.153440. Online ahead of print. Pathol Res Pract. 2021. PMID: 33857854
572 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page